Hard to Treat Diseases, Inc. (HTDS) 股价，以美元计价

The company operates 2 medical and a cosmetics company subsidiaries in Europe, and Mainland China. HTDS is a parent co with operations in an East European medical company (Serbia) Slavica Bio Chem Co; in China Mellow Hope Inc. Slavica's primary focus involves the enhancement and modification of existing approved drugs such as "Virazole" for the purpose of chemical repair of damage to the CNS (central nervous system), MS (Multiple Sclerosis), SARS, Hepatitis C and HIV. Mellow Hope is China based and the biggest exporter of Biological Vaccines in China. It has a product line that encompasses vaccines for influenza, tetanus, diphtheria and other diseases; Blood based products including human rabies immunoglobulin; and active pharmaceutical ingredient (or APIs) for injection such as celestat in. The company is also in the process of developing its own stem cell bank, and in the final stages of a merger with an Israeli prenatal pharmaceutical company.